Document Type
Article
Publication Date
11-15-2024
Abstract
Targeted radionuclide therapy (TRT) for internal pathway-directed treatment is a game changer for precision medicine. TRT improves tumor control while minimizing damage to healthy tissue and extends the survival for patients with cancer. The application of theranostic-paired TRT along with cellular phenotype and genotype correlative analysis has the potential for malignant disease management. Chelation chemistry is essential for the development of theranostic-paired radiopharmaceuticals for TRT. Among image-guided TRT,
Recommended Citation
Tomiyoshi, Katsumi; Wilson, Lydia J.; Mourtada, Firas; Sims Mourtada, Jennifer; Namiki, Yuta; Kamata, Wataru; Yang, David J.; and Inoue, Tomio, "Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology" (2024). Department of Radiation Oncology Faculty Papers. Paper 200.
https://jdc.jefferson.edu/radoncfp/200
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
PubMed ID
39598580
Language
English
Comments
This article is the author's final published version in Pharmaceutics, Volume 16, Issue 11, November 2024, Article number 1458.
The published version is available at https://doi.org/10.3390/pharmaceutics16111458.
Copyright © 2024 by the authors